A proposal of clinical breakpoints for amoxicillin applicable to porcine respiratory tract pathogens von Schwarz, Stefan, Böttner, Alexander, Goosens, Luc, Hafez, H. Mohamed, Hartmann, Katrin, Kaske, Martin, Kehrenberg, Corinna, Kietzmann, Manfred, Klarmann, Dieter, Klein, Günter, Krabisch, Peter, Luhofer, Gabriele, Richter, Angelika, Schulz, Bianka, Sigge, Claudia, Waldmann, Karl-Heinz, Wallmann, Jürgen, Werckenthin, Christiane

Volltext

Erratum to “A proposal of clinical breakpoints for amoxicillin applicable to porcine respiratory tract pathogens” [Vet. Microbiol. 126 (2008) 178–188] von Schwarz, Stefan, Böttner, Alexander, Goossens, Luc, Hafez, H. Mohamed, Hartmann, Katrin, Kaske, Martin, Kehrenberg, Corinna, Kietzmann, Manfred, Klarmann, Dieter, Klein, Günter, Krabisch, Peter, Luhofer, Gabriele, Richter, Angelika, Schulz, Bianka, Sigge, Claudia, Waldmann, Karl-Heinz, Wallmann, Jürgen, Werckenthin, Christiane

Volltext

Results of an interlaboratory test on antimicrobial susceptibility testing of bacteria from animals by broth microdilution von Wallmann, Jürgen, Böttner, Alexander, Goossens, Luc, Hafez, H. Mohamed, Hartmann, Katrin, Kaspar, Heike, Kehrenberg, Corinna, Kietzmann, Manfred, Klarmann, Dieter, Klein, Günter, Krabisch, Peter, Kühn, Tilman, Luhofer, Gabriele, Richter, Angelika, Schulz, Bianka, Schwarz, Stefan, Sigge, Claudia, Traeder, Wolfgang, Waldmann, Karl-Heinz, Werckenthin, Christiane, Zschiesche, Eva

Volltext

Tumor-Infiltrating Lymphocytes: A Predictive and Prognostic Biomarker in Neoadjuvant-Treated HER2-Positive Breast Cancer von Ingold Heppner, Barbara, Untch, Michael, Denkert, Carsten, Pfitzner, Berit M, Lederer, Bianca, Schmitt, Wolfgang, Eidtmann, Holger, Fasching, Peter A, Tesch, Hans, Solbach, Christine, Rezai, Mahdi, Zahm, Dirk M, Holms, Frank, Glados, Manfred, Krabisch, Petra, Heck, Esther, Ober, Angelika, Lorenz, Petra, Diebold, Kurt, Habeck, Jörg-Olaf, Loibl, Sibylle

Volltext

Rucaparib maintenance treatment for recurrent ovarian carcinoma after response to platinum therapy (ARIEL3): a randomised, double-blind, placebo-controlled, phase 3 trial von Coleman, Robert L, Oza, Amit M, Lorusso, Domenica, Aghajanian, Carol, Oaknin, Ana, Dean, Andrew, Colombo, Nicoletta, Weberpals, Johanne I, Clamp, Andrew, Scambia, Giovanni, Leary, Alexandra, Holloway, Robert W, Gancedo, Margarita Amenedo, Fong, Peter C, O'Malley, David M, Armstrong, Deborah K, Garcia-Donas, Jesus, Swisher, Elizabeth M, Floquet, Anne, Konecny, Gottfried E, McNeish, Iain A, Scott, Clare L, Cameron, Terri, Maloney, Lara, Goble, Sandra, Grace, Caroline, Harding, Thomas C, Raponi, Mitch, Sun, James, Lin, Kevin K, Giordano, Heidi, Ledermann, Jonathan A, Buck, M, Dean, A, Friedlander, M L, Harnett, P, Scott, C L, Dirix, L, Vergote, I, Elit, L, Ghatage, P, Oza, A M, Plante, M, Provencher, D, Weberpals, J I, Floquet, A, Joly, F, Leary, A, Medioni, J, Tredan, O, You, B, El-Balat, A, Hänle, C, Krabisch, P, Neunhöffer, T, Pölcher, M, Wimberger, P, Amit, A, Kovel, S, Leviov, M, Safra, T, Shapira-Frommer, R, Stemmer, S, Bologna, A, Colombo, N, Lorusso, D, Sabbatini, R F, Scambia, G, Tamberi, S, Zamagni, C, Fong, P C, O'Donnell, A, Gancedo, M Amenedo, Garcia-Donas, J, Guerra, E M, Oaknin, A, Palacio, I, Romero, I, Sanchez, A, Banerjee, S N, Drew, Y, Jackson, D, Ledermann, J A, McNeish, I A, Parkinson, C, Powell, M, Buss, M K, Chambers, S K, Chen, L-m, Coleman, R L, Holloway, R W, Konecny, G E, Ma, L, Morgan, M A, Morris, R T, O'Malley, D M, Slomovitz, B M, Swisher, E M, Vanderkwaak, T, Vulfovich, M

Volltext

A Phase 3 Trial of Bevacizumab in Ovarian Cancer von Perren, Timothy J, Swart, Ann Marie, Pfisterer, Jacobus, Ledermann, Jonathan A, Pujade-Lauraine, Eric, Kristensen, Gunnar, Carey, Mark S, Beale, Philip, Cervantes, Andrés, Kurzeder, Christian, Bois, Andreas du, Sehouli, Jalid, Kimmig, Rainer, Stähle, Anne, Collinson, Fiona, Essapen, Sharadah, Gourley, Charlie, Lortholary, Alain, Selle, Frédéric, Mirza, Mansoor R, Leminen, Arto, Plante, Marie, Stark, Dan, Qian, Wendi, Parmar, Mahesh K.B, Oza, Amit M

Volltext

Bevacizumab and platinum-based combinations for recurrent ovarian cancer: a randomised, open-label, phase 3 trial von Shannon, Catherine M, Joly, Florence, Sehouli, Jalid, Canzler, Ulrich, Schmalfeldt, Barbara, Dean, Andrew P, Hein, Alexander, Zeimet, Alain G, Petit, Thierry, Marmé, Frederik, El-Balat, Ahmed, Glasspool, Rosalind, Mahner, Sven, Park-Simon, Tjoung-Won, Mouret-Reynier, Marie-Ange, Costan, Cristina, Reinthaller, Alexander, Goh, Jeffrey C, Kommoss, Stefan, Kurtz, Jean-Emmanuel, Ackermann, Sven, Anthuber, Christoph, Aydogdu, Mustafa, Baldauf, Angelika, Behringer, Dirk, Belau, Antje, Bender, Alexandra, Burges, Alexander, Canzler, Ulrich, Daabach, Trygve, Deryal, Mustafa, El-Balat, Ahmed, Fehm, Tanja, Feisel-Schwickardi, Gabriele, Frank, Matthias, Gebauer, Gerhard, Gerber, Bernd, Gerhardt, Axel, Grafe, Andrea, Griesshammer, Martin, Gropp-Meier, Martina, Hager, Dietrich, Hannig, Carla Verena, Hantschmann, Peer, Harter, Philipp, Hauzenberger, Tanja, Herwig, Uwe, Hilpert, Felix, Jackisch, Christian, Krieger, Peter, Lampe, Björn, Lex, Benno, Lorenz, Ralf, Mahner, Sven, Mallmann, Peter, Marmé, Frederik, Möbus, Volker, Müller, Thomas, Neunhöffer, Tanja, Ober, Angelika, Rautenberg, Beate, Reiter, Wilhelm, Schmalfeldt, Barbara, Scholz, Heinz, Simon, Eike, Sperfeld, Antje, Terhaag, Jürgen, Uleer, Christoph, Vogel, Susanne, Voß, Hermann, Winkler, Ulrich, Wischnik, Arthur, Zorr, Andreas, Glasspool, Ros, Jones, Rachel, Lafleur, Judith, Marth, Christian, Baron-Hay, Sally, Beale, Philip, Begbie, Stephen, Harvey, Sandra, Matos, Marco, Meniawy, Tarek, Olesen, Inger, Shannon, Catherine, Abadie-Lacourtoisie, Sophie, Arsene, Olivier, Barthier, Sophie, Catala, Stéphanie, Dohollou, Nadine, Garnier-Tixidré, Claire, Guardiola, Emmanuel, Hardy-Bessard, Anne-Claire, Joly, Florence, Levache, Charles-Briac, Longo, Raffaele, Lortholary, Alain, Meunier, Jérôme, Raban, Nadia, Vannetzel, Jean-Michel

Volltext

Anastrozole for prevention of breast cancer in high-risk postmenopausal women (IBIS-II): an international, double-blind, randomised placebo-controlled trial von Cuzick, Jack, Prof, Sestak, Ivana, PhD, Forbes, John F, Prof, Dowsett, Mitch, Prof, Knox, Jill, MSc, Cawthorn, Simon, MD, Saunders, Christobel, Prof, Roche, Nicola, MD, Mansel, Robert E, Prof, von Minckwitz, Gunter, MD, Bonanni, Bernardo, MD, Palva, Tiina, MD, Howell, Anthony, Prof

Volltext

De-escalated neoadjuvant pertuzumab plus trastuzumab therapy with or without weekly paclitaxel in HER2-positive, hormone receptor-negative, early breast cancer (WSG-ADAPT-HER2+/HR–... von Nitz, Ulrike, Gluz, Oleg, Graeser, Monika, Christgen, Matthias, Kuemmel, Sherko, Grischke, Eva-Maria, Braun, Michael, Augustin, Doris, Potenberg, Jochem, Krauss, Katja, Schumacher, Claudia, Forstbauer, Helmut, Reimer, Toralf, Stefek, Andrea, Fischer, Hans Holger, Pelz, Enrico, zu Eulenburg, Christine, Kates, Ronald, Wuerstlein, Rachel, Kreipe, Hans Heinrich, Harbeck, Nadia, von Schumann, Raquel, Kuhn, Walther, Polata, Silke, Bielecki, Wojciech, Meyer, Ralf, Just, Marianne, Kraudelt, Susanne, Siggelkow, Wulf, Wortelmann, Heidi, Kleine-Tebbe, Anke, Leitzen, Lena, Kirchhof, Heidrun, Krabisch, Petra, Hackmann, John, Depenbusch, Reinhard, Gnauert, Karsten, Staib, Peter, Lehnert, Antje, Hoffmann, Oliver, Briest, Susanne, Lindner, Christoph, Heyl, Volker, Bauer, Leila, Uleer, Christoph, Mohrmann, Svjetlana, Viehstaedt, Nicole, Malter, Wolfram, Link, Theresa, Buendgen, Nana, Tio, Joke

Volltext

Standard first-line chemotherapy with or without nintedanib for advanced ovarian cancer (AGO-OVAR 12): a randomised, double-blind, placebo-controlled phase 3 trial von du Bois, Andreas, Prof, Kristensen, Gunnar, Prof, Ray-Coquard, Isabelle, Prof, Reuss, Alexander, MSc, Pignata, Sandro, MD, Colombo, Nicoletta, Prof, Denison, Ursula, MD, Vergote, Ignace, Prof, del Campo, Jose M, MD, Ottevanger, Petronella, PhD, Heubner, Martin, MD, Minarik, Thomas, PhD, Sevin, Emmanuel, MD, de Gregorio, Nikolaus, MD, Bidziński, Mariusz, Prof, Pfisterer, Jacobus, Prof, Malander, Susanne, MD, Hilpert, Felix, Prof, Mirza, Mansoor R, MD, Scambia, Giovanni, Prof, Meier, Werner, Prof, Nicoletto, Maria O, MD, Bjørge, Line, Prof, Lortholary, Alain, MD, Sailer, Martin Oliver, PhD, Merger, Michael, MD, Harter, Philipp, MD

Volltext

Lapatinib versus trastuzumab in combination with neoadjuvant anthracycline-taxane-based chemotherapy (GeparQuinto, GBG 44): a randomised phase 3 trial von Untch, Michael, Prof, Loibl, Sibylle, MD, Bischoff, Joachim, MD, Eidtmann, Holger, MD, Kaufmann, Manfred, Prof, Blohmer, Jens-Uwe, Prof, Hilfrich, Jörn, Prof, Strumberg, Dirk, Prof, Fasching, Peter A, Prof, Kreienberg, Rolf, Prof, Tesch, Hans, Prof, Hanusch, Claus, MD, Gerber, Bernd, Prof, Rezai, Mahdi, MD, Jackisch, Christian, Prof, Huober, Jens, Prof, Kühn, Thorsten, Prof, Nekljudova, Valentina, PhD, von Minckwitz, Gunter, Prof

Volltext

Efficacy, safety, and prognosis prediction in patients treated with ribociclib in combination with letrozole: Final results of phase 3b RIBECCA study in hormone receptor positive,... von Fasching, Peter A., Decker, Thomas, Hartkopf, Andreas, Nusch, Arnd, Heinrich, Bernhard J., Kurbacher, Christian, Fuchs, Roswitha, Tesch, Hans, Krabisch, Petra, Huober, Jens, Kuemmel, Sherko, Brucker, Sara, Janni, Wolfgang, Schneeweiss, Andreas, Schuler, Martin, Fehm, Tanja, Lüftner, Diana, Quiering, Claudia, Voges, Claudia, Kreuzeder, Julia, Reinisch, Mattea

Volltext

Association between pCR, TILs, and Ki-67 at baseline and after 2 weeks in patients with triple-negative breast cancer (TNBC) treated with atezolizumab and chemotherapy +/- a preced... von Erber, Ramona, Kolberg, Hans-Christian, Schumacher, Johannes, Braun, Michael, Fasching, Peter A., Grischke, Eva-Maria, Schem, Christian, Lux, Michael Patrick, Deryal, Mustafa, Hoffmann, Oliver, Heinrich, Bernhard, Kunz, Georg, Luebbe, Kristina, Krabisch, Petra, Hartmann, Arndt, Raeth, Philip, Kasimir-Bauer, Sabine, Kolberg-Liedtke, Cornelia

Volltext

Neoadjuvant chemotherapy with paclitaxel and everolimus in breast cancer patients with non-responsive tumours to epirubicin/cyclophosphamide (EC) ± bevacizumab – Results of the ran... von Huober, Jens, Fasching, Peter A, Hanusch, Claus, Rezai, Mahdi, Eidtmann, Holger, Kittel, Kornelia, Hilfrich, Jörn, Schwedler, Kathrin, Blohmer, Jens-Uwe, Tesch, Hans, Gerber, Bernd, Höß, Cornelia, Kümmel, Sherko, Mau, Christine, Jackisch, Christian, Khandan, Fariba, Costa, Serban Dan, Krabisch, Petra, Loibl, Sibylle, Nekljudova, Valentina, Untch, Michael, Minckwitz, Gunter von

Volltext

Abstract PS10-31: Ribecca - a phase 3b, multi-center, open label study for women with estrogen receptor positive, locally advanced or metastatic breast cancer treated with ribocicl... von Reinisch, Mattea, Nusch, Arndt, Decker, Thomas, Hartkopf, Andreas, Heinrich, Bernhard J, Kurbacher, Christian M, Fuchs, Roswitha, Tesch, Hans, Krabisch, Petra, Brucker, Sara Y, Fehm, Tanja, Janni, Wolfgang, Kuemmel, Sherko, Lüftner, Diana, Schneeweiss, Andreas, Schuler, Martin, Voges, Claudia, Schubert, Joerg, Fasching, Peter A

Volltext

Evaluation of soluble carbonic anhydrase IX as predictive marker for efficacy of bevacizumab: A biomarker analysis from the geparquinto phase III neoadjuvant breast cancer trial von Janning, Melanie, Müller, Volkmar, Vettorazzi, Eik, Cubas‐Cordova, Miguel, Gensch, Victoria, Ben‐Batalla, Isabel, zu Eulenburg, Christine, Schem, Christian, Fasching, Peter A., Schnappauf, Benjamin, Karn, Thomas, Fehm, Tanja, Just, Marianne, Kühn, Thorsten, Holms, Frank, Overkamp, Friedrich, Krabisch, Petra, Rack, Brigitte, Denkert, Carsten, Untch, Michael, Tesch, Hans, Rezai, Mahdi, Kittel, Kornelia, Pantel, Klaus, Bokemeyer, Carsten, Loibl, Sibylle, Minckwitz, Gunter, Loges, Sonja

Volltext

Abstract P1-19-31: RIBECCA - A phase IIIb, multi-center, open label study for women with estrogen receptor positive locally advanced or metastatic breast cancer treated with riboci... von Hartkopf, Andreas, Nusch, Arnd, Decker, Thomas, Reinisch, Mattea, Heinrich, Bernhard J, Kurbacher, Christian, Fuchs, Roswitha, Tesch, Hans, Krabisch, Petra, Brucker, Sara, Fehm, Tanja N, Janni, Wolfgang, Kümmel, Sherko, Lüftner, Diana, Schneeweiss, Andreas, Schuler, Martin H, Voges, Claudia, Schubert, Jörg, Fasching, Peter A

Volltext

Panitumumab in platinum-sensitive epithelial ovarian cancer patients with KRAS wild-type: The PROVE-study, a phase II randomized multicenter study of the North-Eastern German Socie... von Chekerov, Radoslav, Klare, Peter, Krabisch, Petra, Potenberg, Jochem, Heinrich, Georg, Mueller, Lothar, Kurbacher, Christian M., Grischke, Eva-Maria, Braicu, Elena Ioana, Wimberger, Pauline, Sehouli, Jalid

Volltext

RIBECCA: A phase IIIb, multi-center, open label study for women with estrogen receptor positive locally advanced or metastatic breast cancer treated with ribociclib (LEE011) in com... von Fasching, Peter A., Nusch, Arnd, Heinrich, Bernhard, Brucker, Sara, Decker, Thomas, Kurbacher, Christian M., Tesch, Hans, Krabisch, Petra, Mundhenke, Christoph, Fehm, Tanja N., Janni, Wolfgang, Lueftner, Diana, Schneeweiss, Andreas, Schuler, Martin H., Guderian, Gernot, Voges, Claudia, Schubert, Joerg, Kummel, Sherko

Volltext

RIBECCA: A phase IIIb, multicenter, open label study for women with estrogen receptor-positive locally advanced or metastatic breast cancer treated with ribociclib (LEE011) in comb... von Nusch, Arnd, Decker, Thomas, Reinisch, Mattea, Hartkopf, Andreas D., Heinrich, Bernhard, Kurbacher, Christian M., Fuchs, Roswitha Dorothea, Tesch, Hans, Krabisch, Petra, Brucker, Sara, Fehm, Tanja N., Janni, Wolfgang, Kümmel, Sherko, Luftner, Diana, Schneeweiss, Andreas, Schuler, Martin H., Voges, Claudia, Schubert, Joerg, Fasching, Peter A.

Volltext